This webinar reviews drug-drug and drug-drug-gene interactions in the context of drug exposure. A foundation of drug exposure is presented, followed by a discussion of drug-drug and drug-drug-gene interactions. From this webinar, the participant will be able to:
- Define the pharmacogenes related to drug absorption, distribution, metabolism, and excretion
- Describe how drug exposure is related to efficacy/inefficacy and adverse drug events
- Explain how pharmacogene variants influence or do not influence drug exposure
- Provide examples of drug-drug-gene interactions
David F. Kisor, Pharm.D., FCP
Professor of Pharmaceutical Sciences, Director of Pharmacogenomics Education
Learn more about our pharmacogenetics solutions.